<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase II:   No Preparation, Flexible, Dry Physiological Recording Electrodes</AwardTitle>
<AwardEffectiveDate>10/01/2002</AwardEffectiveDate>
<AwardExpirationDate>03/31/2005</AwardExpirationDate>
<AwardTotalIntnAmount>500000.00</AwardTotalIntnAmount>
<AwardAmount>506000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>George B. Vermont</SignBlockName>
</ProgramOfficer>
<AbstractNarration>     This Small Business Innovation Research  Phase II project is to complete the development of a low-cost, no preparation required, flexible dry physiological recording electrode. These electrodes have the potential to significantly improve quality of care and reduce total cost of biopotential signal analysis by reducing the time and preparation required to obtain a good signal and reducing the total cost of fabricating high quality electrodes. The Phase I results showed feasibility of fabricating dry electrode structures on rigid substrates onto low-cost flexible substrates. However, further work is necessary to optimize the fabrication processes and to ensure that the lowest cost and highest performing flexible dry electrode systems and fabrication processes are chosen to establish a solid foundation for future use. The key objectives of this Phase II project include parallel development of two particularly promising fabrication techniques, selection of a single fabrication technique for further development, and testing and evaluation of the capabilities of the  dry electrodes in clinical environments. &lt;br/&gt;     The commercial applications of this project will be  in the area of physiological monitoring of patients in a clinical setting. Physiological measurements such as ECG (electrocardiogram), EMG (electromyogram), and EEG (electroencephalogram) are expected to benefit from the use of dry electrodes, in part due to the reduced time and preparation needed to apply the electrodes and in part, due to the elimination of abrasive skin prepping and electrolytic gels in the measurement procedure.&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>09/17/2002</MinAmdLetterDate>
<MaxAmdLetterDate>08/27/2004</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0216284</AwardID>
<Investigator>
<FirstName>Frederick</FirstName>
<LastName>Lisy</LastName>
<EmailAddress>lisy@orbitalresearch.com</EmailAddress>
<StartDate>09/17/2002</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>ORBITAL RESEARCH INC</Name>
<CityName>CLEVELAND</CityName>
<ZipCode>441033373</ZipCode>
<PhoneNumber>2166490399</PhoneNumber>
<StreetAddress>4415 EUCLID AVE Suite 500</StreetAddress>
<CountryName>United States</CountryName>
<StateName>Ohio</StateName>
<StateCode>OH</StateCode>
</Institution>
<FoaInformation>
<Code>0308000</Code>
<Name>Industrial Technology</Name>
</FoaInformation>
<FoaInformation>
<Code>0116000</Code>
<Name>Human Subjects</Name>
</FoaInformation>
<ProgramElement>
<Code>5373</Code>
<Text>SBIR Phase II</Text>
</ProgramElement>
<ProgramReference>
<Code>9178</Code>
<Text>UNDERGRADUATE EDUCATION</Text>
</ProgramReference>
<ProgramReference>
<Code>9181</Code>
<Text>BIOPROCESSING/BIOMOLECULAR MATERIALS</Text>
</ProgramReference>
<ProgramReference>
<Code>9251</Code>
<Text>REU SUPP-Res Exp for Ugrd Supp</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
</Award>
</rootTag>
